Somatostatin (SRIF) receptor subtype 2 and 5 gene expression in growth hormone-secreting pituitary adenomas: The relationship with endogenous SRIF activity and response to octreotide

Endocrine Journal

Volumn 51, Issue 2, 2004, Pages 227-236

  Park, Cheolyoung ^a   Yang, Inmyung ^b   Woo, Jeongtaek ^b   Kim, Sungwoon ^b   Kim, Jinwoo ^b   Kim, Youngseol ^b   Sohn, Sookjin ^b   Kim, Eunhee ^b   Lee, Mina ^b   Park, Heesoon ^b   Jung, Jeechang ^b   Park, Seungjoon ^b  

^a Hallym University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Gsp oncogene; Hypothalamic somatostatinergic activity; Pituitary adenomas; Somatostatin receptor

Indexed keywords

GLUCOSE; GROWTH HORMONE; MESSENGER RNA; OCTREOTIDE; PROTIRELIN; THYROTROPIN;

ACROMEGALY; ADULT; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; GENE; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GSP ONCOGENE; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; ONCOGENE; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATOSTATIN RECEPTOR SUBTYPE 2 GENE; SOMATOSTATIN RECEPTOR SUBTYPE 5 GENE; THYROTROPIN RELEASE; TRANSCRIPTION REGULATION;

ACROMEGALY; ADENOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GENE EXPRESSION; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PITUITARY NEOPLASMS; RECEPTORS, SOMATOSTATIN; TREATMENT OUTCOME;

EID: 20844461864     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.227     Document Type: Article

References (29)

1. Lamberts SW, Krenning EP, Reubi JC (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12: 450-482.
2. Lamberts SW (1988) The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr Rev 9: 417-436.
3. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F, Schule R (1993) Cloning and characterization of a fourth human somatostatin receptor. Proc Natl Acad Sci USA 90: 4196-4200.
4. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci USA 89: 251-255.
5. Greenman Y, Melmed S (1994) Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab 78: 398-403.
6. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A (1995) Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab 80: 1386-1392.
7. Reisine T, Bell GI (1995) Molecular biology of somatostatin receptors. Endocr Rev 16: 427-442.
8. Rohrer SP, Hayes E, Berk SC, Hutchins SM, Shen D-M, Xiong Y, Parma R, Foor P, Mitra SW, Degrado SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WW, Pasternak A, Yang L, Patchett A, Smith RG, Chapman KT, Schaeffer JM (1998) Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282: 737-740.
9. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S (1997) Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99: 789-798.
10. Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD, Melmed S (1997) Somatostatin receptor (SSTR) subtype selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas: novel potential therapy for functioning pituitary tumors. J Clin Invest 100: 2386-2392.
11. Bertherat J, Chanson P, Dewailly D, Dupuy M, Jaquet P, Peillon F, Epelbaum J (1993) Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. J Clin Endocrinol Metab 77: 1577-1583.
12. Merola B, Colao A, Cataldi M, Rossi E, Longobardi S, Caruso E, Lombardi G (1992) Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly. Horm Res 37: 7-13.
13. Yang I, Park S, Woo J, Kim S, Kim J, Kim Y, Choi Y (1997) Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients. J Clin Endocrinol Metab 82: 2492-2496.
14. Aleppo G, Moskal SFI, DeGrandis PA, Kineman RD, Frohman LA (1997) Homologous down-regulation of growth hormone-releasing hormone receptor mRNA levels. Endocrinology 138: 1058-1065.
15. Collins S, Caron MG, Lefkowitz RJ (1992) From ligand binding to gene expression: new insights into the regulation of G-protein-couple receptors. Trends Biochem Sci 17: 37-39.
16. Barlier A, Gunz G, Zamora AJ, Morange-Ramos I, Figarella-Branger D, Dufour H, Enjalbert A, Jaquet P (1998) Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. J Clin Endocrinol Metab 83: 1604-1610.
17. Spada A, Arosio M, Bochicchio D, Bazzoni N, Vallar L, Bassetti M, Faglia G (1990) Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71: 1421-1426.
18. Yang I, Park S, Ryu M, Woo J, Kim S, Kim J, Kim Y, Choi Y (1996) Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients. Eur J Endocrinol 134: 720-726.
19. Yang I, Woo J, Kim S, Kim J, Kim Y, Choi Y (1996) Suppression of TRH-stimulated TSH secretion by glucose-induced hypothalamic somatostatin release. Horm Metab Res 28: 553-557.
20. Greenman Y, Melmed S (1994) Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 79: 724-729.
21. Shibasaki T, Masuda A, Hotta M, Yamauchi N, Hizuka N, Takano K, Demura H, Shizume K (1989) Effects of ingestion of glucose on GH and TSH secretion: Evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients. Life Sci 44: 431-438.
22. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179: 77-79.
23. Bouvier C, Forget H, Lagace G, Drews R, Sinnett D, Labuda D, Collu R (1991) G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors. Mol Cell Endocrinol 78: 33-44.
24. Caccavelli L, Morange-Ramos I, Kordon C, Jaquet P, Enjalbert A (1996) Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas. J Neuroendocrinol 8: 737-746.
25. Ballare E, Persani L, Lania AG, Filopanti M, Giammona E, Corbetta S, Mantovani S, Arosio M, Beck-Peccoz P, Faglia G, Spada A (2001) Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. J Clin Endocrinol Metab 86: 3809-3814.
26. s and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692-696.
27. Patel YC, Greenwood M, Kent G, Panetta R, Srikant CB (1993) Multiple gene transcript of the somatostatin receptor SSTR2: Tissue selective distribution and cAMP regulation. Biochem Biophys Res Commun 192: 288-294.
28. Park S, Kamegai J, Johnson TA, Frohman LA, Kineman RD (2000) Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis. Endocrinology 141: 3556-3563.
29. Corbetta S, Ballare E, Mantovani G, Lania A, Losa M, Di Blasio AM, Spada A (2001) Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression. Eur J Clin Invest 31: 208-214.